[Federal Register Volume 59, Number 205 (Tuesday, October 25, 1994)] [Unknown Section] [Page 0] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 94-26376] [[Page Unknown]] [Federal Register: October 25, 1994] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES 21 CFR Part 524 [Docket No. 94N-0202] Nitrofurazone Solution; Removal of Regulation AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is removing the regulation which reflects approval of three new animal drug applications (NADA's) providing for the use of nitrofurazone solution drug products. Additionally, approval of those portions of a fourth NADA (sponsored by SmithKline Beecham Animal Health) which provide for use of nitrofurazone solution product is also being withdrawn, but that approval is not codified. All four sponsors submitted written requests that the agency withdraw the approvals. EFFECTIVE DATE: November 3, 1994. FOR FURTHER INFORMATION CONTACT: Mohammad I. Sharar, Center for Veterinary Medicine (HFV-216), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-594-0749. SUPPLEMENTARY INFORMATION: In a notice published elsewhere in this issue of the Federal Register, FDA is withdrawing approval of three NADA's and those portions of NADA 6-475 providing for the use of nitrofurazone solution. The withdrawals of approval were requested in writing by the sponsors after FDA informed them that new information establishes that the labeled directions for use of the 0.2 percent nitrofurazone solutions have not been followed in practice. The NADA's are: ------------------------------------------------------------------------ Sponsor NADA No. ------------------------------------------------------------------------ SmithKline Beecham Animal Health, 1600 Paoli Pike, West Chester, PA 19380 6-475 Veterinary Laboratories, Inc., 12340 Santa Fe Dr., Lenexa, KS 66215 121-559 Fermenta Animal Health Co., 10150 North Executive Hills Blvd., Kansas City, MO 64153 126-023 Med-Pharmex, Inc., Biomed Laboratories, 325 East Arrow Hwy., San Dimas, CA 91773 126-950 ------------------------------------------------------------------------ The NADA's provide for over-the-counter use of 0.2 percent nitrofurazone solution on dogs, cats, and horses for prevention or treatment of topical bacterial infections, and prescription use for female equine genital tract infections and impaired fertility due to strains of certain bacteria. This document removes 21 CFR 524.1580d, the regulation which reflects the approvals. List of Subjects in 21 CFR Part 524 Animal drugs. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 524 is amended as follows: PART 524--OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 524 continues to read as follows: Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). Sec. 524.1580d [Removed] 2. Section 524.1580d Nitrofurazone solution is removed and reserved. Dated: September 21, 1994. Stephen F. Sundlof, Director, Center for Veterinary Medicine. [FR Doc. 94-26376 Filed 10-24-94; 8:45 am] BILLING CODE 4160-01-F